Results for “”

Entry Author Date Location
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Nestlé to Swallow Up Peanut Allergy Drug Maker Aimmune in $2.6B Deal 08/31/20 San Francisco
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies 08/26/20 San Francisco
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
FDA Rejects Tricida Chronic Kidney Disease Drug, More Data Needed 08/25/20 San Francisco
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data 08/19/20 National
Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program’s End 08/18/20 San Francisco
Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug 08/18/20 San Francisco
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor 08/17/20 Boston
Sanofi Reaches $3.68B Deal to Buy Principia and Partnered MS Drug 08/17/20 Europe
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia 08/12/20 San Francisco
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds 08/06/20 San Francisco
IgGenix Grabs $10M to Advance Antibody Treatments for Allergies 08/05/20 San Francisco
As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up 08/05/20 New York
CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage 08/04/20 San Francisco
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug 07/29/20 Europe
Nura Bio Debuts With $73M and Plan to Develop “Neuroprotective” Drugs 07/29/20 San Francisco
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC 07/23/20 San Francisco
Seer Raises $55M to Commercialize Tools to Analyze the Proteome 07/22/20 San Francisco
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
Page 2 of 106 « previous page · next page »